United Kingdom· GB-APID-43346711000001103
Mepsevii 10mg/5ml concentrate for solution for infusion vials
A vestronidase alfa product containing vestronidase alfa, registered in United Kingdom by Ultragenyx UK Ltd. The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Vestronidase alfa is registered in 10 of 19 countries.
Countries holding a registration under ATC A16AB18 (vestronidase alfa), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 6 of them publish a price we can compare per daily dose
Vestronidase alfa · ATC A16AB18
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Vestronidase alfa
- Manufacturer
- Ultragenyx UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- A16AB18
- ATC class
- Vestronidase alfa
- Defined daily dose
- 20 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin04062343001010
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vestronidase alfa in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumMepsevii 2 mg/mlUltragenyx Germany
- CzechiaMEPSEVIIUltragenyx Germany GmbH, Berlín
- SpainMEPSEVII 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONUltragenyx Germany Gmbh
- FinlandMepseviiUltragenyx Germany GmbH
- IcelandMepseviiUltragenyx Germany GmbH
- Japanベストロニダーゼ アルファ（遺伝子組換え）Ｕｌｔｒａｇｅｎｙｘ Ｊａｐａｎ
- NetherlandsMepsevii 2 mg/ml concentraat voor oplossing voor infusieUltragenyx Germany GmbH
- PolandMepseviiUltragenyx Germany GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Mepsevii
- Liechtenstein · Mepsevii
- Norway · Mepsevii
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3b7ac24a-f19b-423a-9071-b00c3821bc7b GET /v1/drugs/3b7ac24a-f19b-423a-9071-b00c3821bc7b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "43346711000001103",
"desc": "Mepsevii 10mg/5ml concentrate for solution for infusion vials (Ultragenyx UK Ltd)",
"form": "Solution for infusion",
"vpid": "43534111000001107",
"source": "dmd",
"vtm_id": "777929000",
"strength": "2 mg",
"substance": "Vestronidase alfa",
"ingredient": "Vestronidase alfa",
"supplier_code": "42640211000001106"
}See everything about vestronidase alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.